The mission of the Cell Biology & Microinjection component of Reproductive Sciences is to provide CancerCenter members with access to centralized facilities, instrumentation and technical expertise necessary toallow investigators to carry out embryonic stem (ES) cell line derivation, electroporation, and to creategenetically modified mice for in vivo studies of gene function. The Service generates genetically modifiedmice on a variety of inbred strain and hybrid backgrounds and has derived germline-competent ES celllines from inbred mouse strains. Germline-competence validation, training, custom projects, and testedreagents and supplies are also offered. The Service, which has previously been supported by CancerCenter support grant (CCSG) funds, works closely with Cryopreservation, Importation and Rederivationwithin Reproductive Sciences, as well as Phenotyping Sciences to provide Cancer Center members wellintegrated comprehensive services. In 2004 the Cell Biology & Microinjection Service merged with theReproductive Technologies Resource to form Reproductive Sciences. The synergy created by the mergerallowed management and staff to identify complementary and overlapping functions within the groups;establish new collaborative service offerings; merge similar processes to eliminate redundancy; andcombine laboratory, vivarium and office space to maximize productivity. Cell Biology & MicroinjectionService personnel work closely with other members of Reproductive Sciences and the Molecular BiologyService to offer Cancer Center investigators seamless access to services. This close internal collaborationinsures that investigators with expertise outside of these areas can fully employ current transgenic andgene targeting technology in their own work by utilizing these interactive services. Senior Staff Scientist Dr.Thomas Gridley was named Faculty Advisor (Project Leader) of Cell Biology & Microinjection Service in1999. He oversees this fee-for-service operation which employs two ES cell technologists, twomicroinjection technologists, a colony manager and senior operational manager. The Service occupies1,899 ft2 of laboratory, vivarium and office space in Research Laboratory Building 4 and the GeneticsResources Building. Dr. Gridley communicates with the Cancer Center users, Service staff and CenterAdministration to ensure that research needs are met in the most efficient, cost-effective and technicallycurrent manner.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA034196-24
Application #
7535433
Study Section
Subcommittee G - Education (NCI)
Project Start
2007-07-01
Project End
2012-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
24
Fiscal Year
2007
Total Cost
$193,999
Indirect Cost
Name
Jackson Laboratory
Department
Type
DUNS #
042140483
City
Bar Harbor
State
ME
Country
United States
Zip Code
04609
Becker, Timothy; Lee, Wan-Ping; Leone, Joseph et al. (2018) FusorSV: an algorithm for optimally combining data from multiple structural variation detection methods. Genome Biol 19:38
Wang, Qianghu; Hu, Baoli; Hu, Xin et al. (2018) Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. Cancer Cell 33:152
Richter, Wolfgang F; Christianson, Gregory J; Frances, Nicolas et al. (2018) Hematopoietic cells as site of first-pass catabolism after subcutaneous dosing and contributors to systemic clearance of a monoclonal antibody in mice. MAbs 10:803-813
Tamura, Ryo; Yoshihara, Kosuke; Saito, Tetsuya et al. (2018) Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions. Oncogenesis 7:4
Rutherford, Sarah C; Fachel, Angela A; Li, Sheng et al. (2018) Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations. Blood 132:e13-e23
Barthel, Floris P; Wesseling, Pieter; Verhaak, Roel G W (2018) Reconstructing the molecular life history of gliomas. Acta Neuropathol 135:649-670
Kim, Hyunsoo; Kumar, Pooja; Menghi, Francesca et al. (2018) High-resolution deconstruction of evolution induced by chemotherapy treatments in breast cancer xenografts. Sci Rep 8:17937
Winer, Benjamin Y; Shirvani-Dastgerdi, Elham; Bram, Yaron et al. (2018) Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection. Sci Transl Med 10:
Barthel, Floris P; Johnson, Kevin C; Wesseling, Pieter et al. (2018) Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults. Neurol Clin 36:421-437
Schechter, Lisa M; Creely, David P; Garner, Cherilyn D et al. (2018) Extensive Gene Amplification as a Mechanism for Piperacillin-Tazobactam Resistance in Escherichia coli. MBio 9:

Showing the most recent 10 out of 1156 publications